Envoy Medical (NASDAQ:COCH – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its rivals? We will compare Envoy Medical to similar companies based on the strength of its analyst recommendations, risk, institutional ownership, dividends, valuation, earnings and profitability.
Risk & Volatility
Envoy Medical has a beta of 2.03, meaning that its stock price is 103% more volatile than the S&P 500. Comparatively, Envoy Medical’s rivals have a beta of 2.57, meaning that their average stock price is 157% more volatile than the S&P 500.
Insider & Institutional Ownership
8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 7.2% of Envoy Medical shares are held by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Envoy Medical and its rivals revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Envoy Medical | $240,000.00 | -$23.76 million | -1.55 |
| Envoy Medical Competitors | $1.88 billion | $136.81 million | 10.34 |
Envoy Medical’s rivals have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Envoy Medical and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Envoy Medical | 1 | 1 | 2 | 0 | 2.25 |
| Envoy Medical Competitors | 4279 | 10550 | 18327 | 829 | 2.46 |
Envoy Medical currently has a consensus target price of $21.67, suggesting a potential upside of 203.03%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.20%. Given Envoy Medical’s higher probable upside, research analysts plainly believe Envoy Medical is more favorable than its rivals.
Profitability
This table compares Envoy Medical and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Envoy Medical | -9,026.41% | -5,250.23% | -110.01% |
| Envoy Medical Competitors | -304.51% | -178.77% | -22.17% |
Summary
Envoy Medical rivals beat Envoy Medical on 11 of the 12 factors compared.
Envoy Medical Company Profile
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
